Method of treating abnormal lipid metabolism
AssigneeMitsubishi Tanabe Pharma Corporation
InventorsYuji ABE, Aki KUSUNOKI, Yoshiharu HAYASHI, Fumihiko AKAHOSHI
Life of this patent
Estimating the term…
Abstract
The present invention provides a pharmaceutical agent for the treatment and/or prophylaxis of abnormal blood glucose and lipid metabolism associated with eating, for which a sufficient treatment method or a therapeutic drug has not been found.
Claims6
A method of treating an abnormal lipid metabolism in a subject by administering to a subject having an abnormal lipid metabolism a salt of 3-{(2S,4S)-4-[4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)piperazin-1-yl]pyrrolidin-2-ylcarbonyl}thiazolidine with an organic or inorganic mono- or di-basic acid, or a hydrate thereof to treat the abnormal lipid metabolism.
A method of treating an abnormal lipid metabolism in a subject comprising administering to a subject having an abnormal lipid metabolism 3-{(2S,4S)-4-[4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)piperazin-1-yl]pyrrolidin-2-ylcarbonyl}thiazolidine 2.5 hydrobromide, or a hydrate thereof to treat the abnormal lipid metabolism.
Dependencies are inferred from the claim text.